Barbara Weber, M.D.
Tango Therapeutics, Inc.
Barbara Weber, M.D., is the CEO of Tango Therapeutics, Inc., a biotechnology company focused on developing precision medicines for cancer and other serious diseases. Dr. Webers leadership is marked by a focus on scientific innovation, research excellence, and strategic growth. With extensive experience in oncology and biotechnology, she has guided Tango Therapeutics through significant advancements in drug development and clinical research. Her commitment to advancing precision medicine and improving patient outcomes continues to drive Tango Therapeutics success and innovation in the biotech industry.